• 1. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 2. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 3. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 4. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

Benzoic acid, 2-(4-aminophenyl)hydrazide (CAS No. 63402-27-7): A Comprehensive Overview

Benzoic acid, 2-(4-aminophenyl)hydrazide, identified by the Chemical Abstracts Service Number (CAS No.) 63402-27-7, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic hydrazide derivative has garnered considerable attention due to its versatile applications in medicinal chemistry, particularly in the development of novel therapeutic agents. The compound's unique structural features, encompassing both a benzoic acid moiety and an amino phenyl group linked via a hydrazine bridge, make it a valuable intermediate in synthetic pathways targeting various biological targets.

The< strong>benzoic acid component of this molecule contributes to its acidic properties, which can be leveraged in various chemical reactions, including condensation and esterification processes. This feature is particularly useful in the synthesis of more complex derivatives aimed at enhancing pharmacological activity. Concurrently, the< strong>4-aminophenyl moiety introduces basicity and potential aromatic interactions, which are crucial for binding to biological receptors and modulating enzyme activities. Such structural attributes have positioned this compound as a key building block in the design of small-molecule drugs.

In recent years, the pharmaceutical industry has seen a surge in interest for hydrazide-based compounds due to their broad spectrum of biological activities. Research has highlighted their potential in inhibiting various enzymes and receptors involved in inflammatory responses, metabolic disorders, and even certain types of cancer. Specifically, derivatives of< strong>Benzoic acid, 2-(4-aminophenyl)hydrazide have been investigated for their anti-inflammatory properties, with some studies suggesting mechanisms involving the modulation of cyclooxygenase (COX) enzymes and lipoxygenase (LOX) pathways.

One of the most compelling aspects of this compound is its role as a precursor in the synthesis of more complex pharmacophores. For instance, researchers have utilized< strong>Benzoic acid, 2-(4-aminophenyl)hydrazide to develop novel inhibitors targeting specific kinases implicated in cancer progression. These kinases often play pivotal roles in cell signaling cascades that drive tumor growth and metastasis. By designing molecules that specifically interact with these kinases, scientists aim to develop therapies that can selectively inhibit their activity without affecting normal cellular processes.

The< strong>CAS No. 63402-27-7 registry ensures that researchers worldwide can reliably identify and procure this compound for their studies. This standardized identification system is crucial for maintaining consistency in experimental protocols and ensuring reproducibility across different laboratories. Moreover, the growing body of literature on hydrazide derivatives underscores the importance of< strong>Benzoic acid, 2-(4-aminophenyl)hydrazide as a research tool and a potential lead compound for drug discovery.

In addition to its pharmaceutical applications, this compound has also found utility in agrochemical research. Its structural motifs are reminiscent of certain pesticides and herbicides that target specific enzymatic pathways in pests or weeds. By modifying the< strong>benzoic acid-based core or the< strong>4-aminophenyl group, chemists can tailor the properties of these derivatives to enhance their efficacy as crop protection agents while minimizing environmental impact.

The synthesis of< strong>Benzoic acid, 2-(4-aminophenyl)hydrazide typically involves multi-step organic reactions starting from readily available aromatic precursors. The process often begins with the formation of an amine derivative followed by hydrazination with benzoyl chloride or another suitable benzoic acid derivative. Advances in synthetic methodologies have enabled more efficient and scalable production methods, making it easier for industrial and academic researchers to access this compound for their investigations.

Efforts to optimize the synthesis have also focused on improving yields and reducing byproduct formation through catalytic processes or green chemistry principles. For instance, transition metal-catalyzed cross-coupling reactions have been explored as means to construct the hydrazide linkage more efficiently than traditional methods. Such innovations not only enhance the practicality of producing< strong>Benzoic acid, 2-(4-aminophenyl)hydrazide but also align with broader sustainability goals within the chemical industry.

The pharmacological profile of< strong>Benzoic acid, 2-(4-aminophenyl)hydrazide continues to be an area of active investigation. Recent studies have delved into its potential as an antioxidant agent, leveraging its ability to scavenge reactive oxygen species (ROS) and protect cells from oxidative damage. Oxidative stress is implicated in numerous diseases, including neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. Therefore, compounds like< strong>Benzoic acid, 2-(4-aminophenyl)hydrazide, which can mitigate oxidative stress, hold promise as therapeutic candidates.

In conclusion,< strong>Benzoic acid, 2-(4-aminophenyl)hydrazide (CAS No. 63402-27-7) represents a multifaceted compound with significant implications across multiple domains of chemistry and biology. Its unique structural composition makes it a valuable intermediate for synthesizing novel therapeutic agents targeting various diseases. As research progresses，the full potential of this compound is likely to be uncovered，leading to new applications that benefit human health and industrial processes alike.

• 495-73-8(Benquinox)
• 88405-48-5(Benzoic acid, 4-bromo-, 2-(4-bromophenyl)hydrazide)
• 379254-47-4(3-Hydrazinylbenzohydrazide)
• 120277-21-6(7-Methyl-1H-indazol-3-ol)
• 52023-39-9(Benzoicacid, 2-methyl-2-phenylhydrazide)
• 532-96-7(Benzoic acid,2-phenylhydrazide)
• 71315-63-4(Benzoic acid,2-(4-bromophenyl)hydrazide)
• 39719-02-3(Benzoic acid, 4-methyl-, 2-phenylhydrazide)
• 71274-77-6(1-Naphthalenecarboxylic acid, 2-phenylhydrazide)
• 88405-47-4(Benzoic acid, 4-cyano-, 2-phenylhydrazide)